, GHK-Cu: The Anti-Aging Copper Peptide , Anti-Aging Peptides Research , Recovery Peptides Research Guide , and Peptide Stacking Guide
Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials
A typical dosage is 1000 mcg (1 mg) administered IM or subcutaneously
Research Protocols from Published Literature The following represents dosing and administration protocols extracted from published research
What does the company do to ensure the purity of the peptides it sells
I know the syringe and the bubble moves up into the nose of the syringe